N, P., E, H., EM, D., G, S., M, C., PC, C., . . . KJ, C. (2025). PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 66(2), 264. https://doi.org/10.2967/jnumed.124.268713
Chicago Style (17th ed.) CitationN, Prasad, et al. "PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 66, no. 2 (2025): 264. https://doi.org/10.2967/jnumed.124.268713.
MLA (9th ed.) CitationN, Prasad, et al. "PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 66, no. 2, 2025, p. 264, https://doi.org/10.2967/jnumed.124.268713.